Updates

The Rottenstein Law Group which represents clients with claims stemming from the severe adverse side effects of various prescription drugs and complications caused by dangerous medical devices is cataloging the dangers of the prescription drug Pradaxa in anticipation of representing those harmed in lawsuits against the medicine’s manufacturer. The… Read more

The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax has learned that the FDA has published an analysis generally recommending caution when using popular bone-building medications for long terms though without offering more specific suggestions. The agency’s analysis … Read more

The Rottenstein Law Group which represents clients with claims stemming from the adverse effects of vaginal mesh eagerly anticipates the Feb. 15 2013 start date of the first federal-court trial over injuries allegedly sustained by women as a result of having received vaginal mesh implants manufactured by C.R. Bard (MDL No…. Read more

The Rottenstein Law Group which represents clients with claims stemming from the adverse effects of vaginal mesh is heartened by the U.S. Senate’s version of the Medical Device User Fee Bill which requires the FDA to issue a final rule on the use of unique device identifiers (UDIs) that will enable the… Read more

The Rottenstein Law Group which represents clients with claims stemming from the adverse effects of Zoloft a member of the selective serotonin re-uptake inhibitor (SSRI) class of antidepressants is chagrined—but not surprised—by a recently published paper in which a group of researchers state that the harmful side effects of commonly prescribed antidepressants… Read more

The Rottenstein Law Group which represents clients with claims stemming from the failures of defective hip replacement devices manufactured and sold by DePuy Orthopaedics looks forward to the start of the earliest trials concerning the embattled ASR hip implants. Almost two years after DePuy recalled its ASR devices the first… Read more

The Rottenstein Law Group which represents clients with claims stemming from the adverse effects of various medical devices commends the New York Times for having recently published an article explaining why St. Jude Medical’s manufacturing of a defective medical implant that has recently been identified as the possible cause of 20 patient deaths casts doubt… Read more

The Rottenstein Law Group which represents clients with claims stemming from the severe side effects of the drug Fosamax is disheartened to learn that manufacturer Merck is claiming victory in a fifth lawsuit. In a press release dated April 18 Merck & Co. Inc manufacturer of the… Read more

The Rottenstein Law Group is heartened by the FDA’s April 12 2012 expansion of Propecia’s and Proscar’s warning labels to include a broader range of adverse sexual events. “Propecia labels will now include warnings for libido disorders ejaculation disorders and orgasm disorders that continued for men even months… Read more

The Rottenstein Law Group which represents clients with claims stemming from the severe adverse side effects of defective medical devices is fully supportive of the efforts of the U.S. FDA to study the dangers posed by metal-on-metal hip implants. According to a recent Reuters report on June 27-28 the… Read more

The Rottenstein Law Group supports the efforts of Dr. Robert Hauser a medical professional who is pushing for changes at the FDA that will make medical devices safer for consumers.The author of a recent report on deaths tied to St. Jude Medical’s Riata defibrillator leads “Hauser is an active voice in the discussions… Read more

The Rottenstein Law Group is dismayed to learn that first-time users have an increased chance of developing certain inflammatory eye disorders while taking Fosamax to combat osteoporosis. Researchers at the Child and Family Research Institute at the University of British Columbia in Vancouver looked at over 934 000 people who visited ophthalmologists… Read more

The Rottenstein Law Group lauds Consumer Reports for publishing an investigative report describing the shortcomings of the FDA’s medical device approval process. The article/report titled “CR Investigates: Dangerous medical devices ” is dated May 2012 but is already available online. It states that Consumer Reports’ investigation into the FDA’s medical… Read more

The Rottenstein Law Group is fully supportive of the efforts of Congressman Edward J. Markey to achieve “closure of dangerous medical device loophole.” Congressman Edward J. Markey (D-Mass.) late last month released a comprehensive new report titled “Defective Devices Destroyed Lives: Loophole Leaves Patients Unprotected from Flawed Medical Devices.” Rep. Markey’s report highlights… Read more

The Rottenstein Law Group which represents clients with claims stemming from injuries and birth defects caused by the Selective Serotonin Reuptake Inhibitors (SSRIs) Zoloft and Paxil has learned of research showing that pregnant women who take SSRIs to treat their depression face a higher risk of developing dangerously high blood pressure a… Read more

The Rottenstein Law Group is taking note of the initial deadlines set by the Wright Conserve multidistrict litigation court in its first pretrial order. In its Pretrial Order no. 1 filed on March 19 the United States District Court for the Northern District of Georgia in the case styled In… Read more

The Rottenstein Law Group which represents clients with claims stemming from the adverse effects of vaginal mesh is disheartened by a recent news story reporting that Johnson & Johnson sold a vaginal mesh implant for three years before U.S. regulators approved the device which is now the subject of more than 550… Read more

The Rottenstein Law Group has learned of research showing that the fetuses of pregnant women who took SSRIs to treat their depression were twice as likely to be born preterm as the fetuses of both not-depressed pregnant women and the fetuses of women with depression that was left untreated. The study that… Read more

The Rottenstein Law Group is now evaluating cases of those who received a Wright Conserve or Profemur Z device. The Wright Conserve devices compose a hip replacement system that involves the capping of a patient’s thigh bone with a synthetic ball and the replacement of that patient’s hip socket with a corresponding cup. Both the… Read more

The Rottenstein Law Group has learned with some dissatisfaction of a significant setback to four individual lawsuits against Merck & Co. Inc. In September 2005 a putative class of plaintiffs filed a class action against Merck manufacturer of Fosamax in federal court in Tennessee. When all federal Fosamax… Read more